Credo Technology Group (NasdaqGS:CRDO) Q3 2026 Earnings call March 02, 2026 05:00 PM ET Speaker3Ladies and gentlemen, thank you for standing by. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. At that time, if you have a question, you will need to press star followed by 1 on your telephone keypad. If you would like to withdraw your question, press star 1 again. I would now like to turn the conference over to Mr. Daniel O'Neil. Please go ahead, ...

Summary of Elastic (NYSE:ESTC) 2026 Conference Call Company Overview - **Company**: Elastic (NYSE:ESTC) - **Event**: Morgan Stanley TMT Conference - **Date**: March 02, 2026 - **Speakers**: CEO Ash Kulkarni, CFO Navam Welihinda Key Points Industry Context - The current market is focused on the impact of AI on software companies, with investors assessing which companies will remain durable in the AI era [4][10] Core Value Proposition - Elastic positions itself as a data platform that provides context to large language models (LLMs), emphasizing the need to bring models to data rather than moving data to models [5][9] - The company highlights its ability to deliver specific data relevance and context for various AI use cases [9] Financial Performance - **Sales-led subscription revenue growth**: Accelerated to 19% from 17% in the previous quarter [10] - **Operating income**: Remains strong, with a record number of million-dollar deals reported [12] - **AI adoption**: Approximately 25% of the 100K customer cohort is now using Elastic for AI applications [14] Market Trends - There is a growing interest in self-managed environments, particularly in regulated industries where data sensitivity is paramount [14][16] - The demand for running technologies in sovereign environments is increasing in Europe [16] Competitive Advantage - Elastic's ability to offer a comprehensive platform that can be deployed both in cloud and self-managed environments is seen as a significant advantage over competitors [17] - The company emphasizes the importance of its data store and context accuracy as its defensible moat against competitors [34] AI Integration and Growth - Elastic is experiencing increased consumption from AI workloads, with a quantified difference of approximately 6% in consumption between AI users and non-users [51][53] - The company anticipates that AI will serve as a tailwind for growth, with midterm targets set to exceed 20% sales-led subscription revenue growth by fiscal 2029 [57][58] Observability and Security - The observability business is growing, particularly in metrics, which has historically been a weaker area for Elastic [75][80] - The company is developing specialized backend stores to improve performance in observability, expected to launch mid-year [80] Capital Allocation Strategy - Elastic maintains a disciplined approach to stock-based compensation while investing in sales and marketing capacity [92][93] - The company has allocated over 50% of its capital for share repurchases as part of its strategy to return value to shareholders [97] Future Outlook - Elastic expects steady growth rather than a sudden inflection, focusing on long-term market share and efficiency improvements [88][89] - The company is committed to evolving its platform to meet the changing demands of AI and data management [46][67] Additional Insights - Context engineering is defined as the processes and capabilities needed to provide LLMs with accurate context, which Elastic aims to excel in [67][68] - The shift from human to AI interfaces is anticipated to change how data platforms operate, with a focus on APIs over traditional UIs [46][68]

Summary of Hims & Hers Health Conference Call Company Overview - **Company**: Hims & Hers Health (NYSE:HIMS) - **Date**: March 02, 2026 - **Focus**: The company aims to make treatment for stigmatized conditions accessible and enhance consumer awareness. Key Points Industry and Market Position - Hims & Hers has evolved from focusing on awareness and access to personalized treatments, investing hundreds of millions in capital expenditures to enhance capabilities [2][3][4] - The company has over 2.5 million subscribers, allowing it to analyze consumer journeys from intent to outcome [4] Strategic Vision and Growth - Future strategy will leverage historical competencies while aggressively utilizing data to enhance personalized treatments and remove friction points in the consumer journey [5] - Plans for international expansion have been reinforced by recent acquisitions, including Eucalyptus, and a focus on markets like Canada and the UK [9][10] Financial Performance and Projections - The company aims for a revenue target of $6.5 billion and $1.3 billion in EBITDA by 2030 [24] - Each new specialty is projected to achieve a run rate of over $100 million in the near future, with significant market potential in the U.S. and globally [22][23] Marketing and Brand Development - Marketing efficiency improved significantly, with a 7-point increase in marketing as a percentage of revenue year-over-year [12] - The company aims to become the default brand for health and wellness, similar to how consumers associate specific brands with other industries [13][14] New Specialties and Innovations - Focus on recurring conditions and emotionally resonant issues, such as low testosterone and menopause, to drive growth [18][19] - Introduction of at-home diagnostic devices and AI integration to enhance consumer experience and treatment personalization [9][48] International Strategy - The company has a history of international operations and is leveraging domestic cash flow to fund international growth [29][30] - The international market is expected to reach at least $1 billion in revenue in the coming years, with a focus on adapting to local regulatory environments [36] Competitive Landscape - Hims & Hers differentiates itself through a strong brand, extensive subscriber base, and a robust provider network, which enhances its competitive position against larger organizations like Amazon [55][56][57] Challenges and Future Outlook - The company is navigating challenges in the sexual health market but expects to see growth resume in the latter half of the year [40][41] - Continuous monitoring of new specialties and their integration into the platform will be crucial for sustained growth [41][42] Technology and AI Integration - Investments in technology are aimed at improving operational efficiency and enhancing the consumer experience through personalized care and diagnostics [46][50] - The introduction of AI-driven tools, such as care coaches, is expected to further enhance user engagement and treatment outcomes [50][51] Conclusion Hims & Hers Health is strategically positioned for growth through its focus on personalized treatments, international expansion, and technological innovation. The company aims to solidify its brand presence in the health and wellness sector while navigating market challenges and leveraging data-driven insights to enhance consumer experiences.

IMAX Conference Call Summary Company Overview - **Company**: IMAX Corporation (NYSE: IMAX) - **Date**: March 02, 2026 - **Speaker**: Natasha Fernandes, CFO of IMAX Key Industry Insights - **Studio Partnerships**: IMAX collaborates with over 60 content partners globally, including major studios like Paramount, Warner Bros, Netflix, Amazon, MGM, and Apple, as well as local language studios [6][7] - **Impact of Paramount-Warner Merger**: The merger is seen as beneficial for IMAX, enhancing its position in the market and solidifying relationships with key studios [6][7] - **Content Strategy**: IMAX is focusing on a diversified content slate, including local language films, Hollywood content, and alternative content like concert films and live events, which is expected to drive growth [14] Financial Performance and Growth Drivers - **Growth Drivers**: - **Filmed for IMAX Program**: Increased collaboration with filmmakers is leading to higher consumer demand for IMAX films [12] - **Network Expansion**: IMAX's network grew by 3.5% last year, with over 8% growth in international markets and 4% domestically. The company holds over 5% market share domestically with only 1% of screens [13] - **Content Diversification**: The inclusion of local language films and alternative content is expected to enhance utilization and revenue [14] - **Box Office Performance**: IMAX captured $60 million in box office revenue during a weekend with limited competition, showcasing its ability to maximize opportunities [15] Market Dynamics - **China Market**: IMAX has a strong brand presence in China, being one of the top three box office generators. The company is focusing on a diverse slate that includes local language films and Hollywood content [21][22] - **Competitive Differentiation**: IMAX's brand strength, technology, and unique marketing strategies contribute to its competitive edge in the Chinese market [23] Future Outlook - **International Growth**: The Rest of World market presents significant growth opportunities, with only 30% penetration currently. Japan and Australia are highlighted as key growth markets [33][34] - **Financial Guidance**: IMAX is guiding towards $1.4 billion in box office revenue, with expectations for continued growth in domestic and international markets [58] Capital Allocation and Financial Health - **Balance Sheet Strength**: IMAX has successfully refinanced its convertible debt and expanded its revolver, positioning itself well for future investments and share repurchases [39] - **Operating Leverage**: The company reported a 45% EBITDA margin and aims to increase this to over 50% in the coming years through cost management and revenue growth [38] Technological Integration - **AI Utilization**: IMAX is exploring AI applications for operational efficiencies, content programming, and data analysis to enhance revenue generation [43][44] Conclusion - **Execution Focus**: The CFO emphasizes the importance of executing growth strategies effectively and exceeding guidance to deliver value to shareholders [71]

Summary of The New York Times Company Conference Call Company Overview - **Company**: The New York Times Company (NYSE: NYT) - **Date**: March 02, 2026 - **Key Speaker**: Meredith Kopit Levien, President and CEO Core Industry Insights - **Subscriber Growth**: The company reported healthy subscriber growth, revenue growth, and margin expansion in 2025, indicating a successful execution of its subscription strategy [3][6] - **Total Addressable Market (TAM)**: The total audience for The Times is significantly larger than its subscriber base, with 150 million user registrations and 50-100 million weekly visitors to its sites and apps [8][9] - **Market Penetration**: There is substantial room for further market penetration in both domestic and international markets across news and lifestyle products [6][9] Strategic Advantages - **Quality of Products**: Over a decade of investment in product quality has resulted in a more valuable news coverage, especially as competitors retreat [6][7] - **Innovation in Formats**: Continuous innovation in product formats, particularly in video, is expected to drive audience engagement [7][8] - **Multiple Revenue Streams**: The company has developed various revenue streams based on audience engagement, which are anticipated to grow [7][8] Consumer Relationship with News - **Persistent Demand**: There is a consistent demand for news, regardless of external factors like distrust in media or changing consumer habits [13][14] - **Building Trust**: The Times aims to enhance trust through direct relationships and high-quality journalism, leveraging its established brand [15][16] Video Initiative - **Growth Opportunity**: Video is seen as a significant long-term growth opportunity, with ambitions to become a preferred brand for news consumption [38][39] - **Engagement Metrics**: Early engagement metrics from the video tab in the core app are promising, indicating potential for audience growth [40][41] Advertising Strategy - **Advertising Growth**: The advertising business is expected to grow, driven by new supply in games and sports, and the ability to appeal to a broader range of marketers [76][78] - **The Athletic's Role**: The Athletic has been a key contributor to advertising success, particularly in sports coverage [83][84] Financial Considerations - **Expense Growth**: There has been an increase in expenses related to new product innovations, particularly in video, but the company maintains a disciplined approach to ensure revenue growth outpaces expenses [88][89] - **Marketing Strategy**: The primary driver of new subscriptions is product-driven growth, with marketing playing a supportive role [92][94] Conclusion - **Future Outlook**: The New York Times Company is positioned to capitalize on its strengths in journalism and product innovation, with a focus on building engaged audiences and expanding its market presence [95]

Summary of Weave's Conference Call Company Overview - **Company**: Weave - **Industry**: Vertical software and payments platform for healthcare practices - **Focus**: AI-powered patient engagement for small and medium-sized healthcare practices, primarily in dental, optometry, veterinary, and specialty medical sectors [2][18] Core Business Insights - **Revenue**: Weave reported $239 million in revenue for the year, reflecting a 17% year-over-year growth [5][20] - **Free Cash Flow**: Generated nearly $13 million in free cash flow, with a 24% increase year-over-year [5][22] - **Customer Base**: Focuses on well-capitalized, high-quality small and medium-sized businesses with a high retention rate [5][6] - **Churn Rate**: Very low churn rate, indicating strong customer loyalty [6] Product Offerings - **Services**: Provides telephony, patient engagement solutions, payment management, and AI functionalities [3][4] - **AI Receptionist**: New product aimed at enhancing patient engagement and operational efficiency, currently being rolled out [4][19] - **Payment Solutions**: Text to Pay and other modern payment workflows to improve collections and reduce write-off rates [38][39] Market Opportunity - **Total Addressable Market (TAM)**: Estimated at $10 billion in the U.S. for all medical practices, with significant room for growth in specialty medical [18] - **Market Penetration**: Currently about 10% penetrated in the U.S. market, with less than 1% in specialty medical and around 15% in dental [18] Financial Performance - **Gross Margin**: Improved from 57% at IPO to 73.3%, with consistent growth over 15 of the last 16 quarters [20][21] - **Growth Strategy**: Focus on unit economics and operational effectiveness while balancing revenue growth with profitability [45] Competitive Advantages - **Data and Experience**: Decades of industry data and experience create a competitive moat against new entrants [29][30] - **Integrated Solutions**: Offers a comprehensive platform that reduces the need for multiple vendors, enhancing customer satisfaction [43] Future Outlook - **AI Integration**: AI features expected to drive further growth and improve customer engagement [19][24] - **Sales Strategy**: Focus on mid-market and enterprise solutions, with a longer sales cycle but significant growth potential [32][33] - **Customer Engagement**: Emphasis on improving patient engagement and operational efficiency through technology [8][16] Key Takeaways - Weave is well-positioned for growth in the healthcare software market, with a strong focus on AI and patient engagement solutions - The company has demonstrated consistent financial performance and has a clear strategy for expanding its market presence - Future developments, particularly in AI and payment solutions, are expected to enhance value for customers and drive revenue growth [50][51]

Financial Data and Key Metrics Changes - In Q4 2025, the company generated adjusted EBITDA of $220 million, down from $246 million in the prior year, which benefited from approximately $80 million of political revenue [4][17] - Consolidated revenue for the quarter was $1.1 billion, up 0.8% compared to the prior year quarter, exceeding guidance of a low single-digit decline; excluding political impact, revenue was up 7.7% [4][15] - The company reported a GAAP operating income of $86 million compared to $105 million in the prior year quarter [17] Business Line Data and Key Metrics Changes - The Digital Audio Group generated Q4 revenue of $387 million, up 14.1% year-over-year, with adjusted EBITDA of $132 million, up 10.7% [5][19] - The Multiplatform Group's revenue was $665 million, down 2.8% year-over-year, with adjusted EBITDA of $129 million, down 14.2% [9][20] - The Audio and Media Services Group reported revenue of $79 million, down 19.3% year-over-year, but up 21.8% when excluding political revenue [21] Market Data and Key Metrics Changes - The largest advertising categories in Q4 included healthcare, home building and improvement, financial services, retail, and entertainment, while political, government, restaurants, and food and beverage saw declines [15] - The company outperformed the radio industry revenue performance by 500 basis points according to Miller Kaplan [11] Company Strategy and Development Direction - The company aims to return the Multiplatform Group to EBITDA growth by focusing on programmatic advertising, integrated sales, and leveraging its large local sales force [9][10] - The company is investing in broadcast programmatic efforts and expects to generate approximately $200 million in programmatic revenue in 2026, up 50% from 2025 [24][39] Management's Comments on Operating Environment and Future Outlook - Management views the advertising marketplace as reasonably healthy despite some macro uncertainties and expects meaningful EBITDA and free cash flow growth in 2026 [13][26] - The company anticipates a strong non-presidential political cycle in 2026, which is expected to contribute positively to revenue [35][60] Other Important Information - The company is implementing $100 million in cost savings initiatives for 2026, in addition to $150 million achieved in 2025 [18][25] - Free cash flow for Q4 was $138 million, demonstrating high free cash flow conversion characteristics [22] Q&A Session Summary Question: Growth in core MPG revenues and digital side - Management noted that Q1 revenue growth is expected to be high single digits, but EBITDA may decline due to various factors, including the small size of Q1 numbers compared to the rest of the year [28][30] Question: Cost savings cadence - Management provided a breakdown of the $100 million cost savings, estimating $12.5 million for Q1 and $28 million for Q2 [33] Question: Political revenue assumptions for EBITDA guidance - Management expects 2026 to be a strong political year, contributing positively to EBITDA guidance [34] Question: Drivers of growth in podcasting business - Management highlighted multiple growth vectors in podcasting, including increased usage and inventory opportunities, and emphasized the importance of financial discipline in podcast selection [42][44] Question: Video podcasting opportunities - Management sees potential in video podcasting driven by partnerships with platforms like Netflix and YouTube, which could expand revenue opportunities [48][49] Question: Programmatic revenue growth rate - Management indicated that programmatic revenue growth in 2024 to 2025 would be substantially less than in 2025, but specific figures were not provided [56][57]

Core Scientific (NasdaqGS:CORZ) Q4 2025 Earnings call March 02, 2026 04:30 PM ET Company ParticipantsAdam Sullivan - CEOBen Soffins - Equity Research AssociateHenry Hurr - Equity Research AssociateJim Nygaard - CFOJon Charbonneau - Vice President, Investor RelationsJon Hickman - Managing DirectorMatt Brown - COOConference Call ParticipantsBrett Knoblauch - Managing Director and Senior Equity Research AnalystDarren Aftahi - Managing Director and Senior Equity Research AnalystGeorge Sutton - Managing Director ...

Asana (NYSE:ASAN) Q4 2026 Earnings call March 02, 2026 04:30 PM ET Company ParticipantsAziz Megji - Head of Strategic Finance and FP&ABrent Bracelin - Managing Director and Head of Technology Equity Capital MarketsDan Rogers - CEOEva Leung - Head of Investor RelationsJackson Ader - Managing DirectorRishi Jaluria - Managing Director of Software Equity ResearchSonalee Parekh - CFOConference Call ParticipantsJosh Baer - Executive Director and Software Equity Research AnalystRob Oliver - Managing Director and S ...

Nuvation Bio (NYSE:NUVB) Q4 2025 Earnings call March 02, 2026 04:30 PM ET Company ParticipantsColleen Sjogren - CCODavid Hung - Founder, President, and CEOJ.R. DeVita - Executive Director of Corporate Development and Investor RelationsMatthew Taylor - Managing DirectorMayank Mamtani - Senior Managing Director and Group Head of Healthcare ResearchPhilippe Sauvage - CFOConference Call ParticipantsFarzin Haque - Biotechnology Equity Research AnalystGreg Renza - Senior Analyst of BiotechnologyKaveri Pohlman - M ...